The Biology of Aging: Understanding the Hallmarks of Aging
Why do we become more vulnerable to chronic disease as we get older?
There is no single aging gene or pathway responsible. Instead, aging appears to emerge from a network of interconnected changes within our cells and tissues.
Scientists describe many of these processes through a framework known as the Hallmarks of Aging.
Originally introduced with nine hallmarks, the framework was expanded in 2023 to include 12 interconnected biological processes. These hallmarks provide researchers and clinicians with a useful roadmap for understanding aging and, increasingly, identifying potential ways to influence it.
The 12 Hallmarks of Aging
The current hallmarks include:
Genomic instability
Telomere attrition
Epigenetic alterations
Loss of proteostasis
Disabled macroautophagy
Deregulated nutrient sensing
Mitochondrial dysfunction
Cellular senescence
Stem cell exhaustion
Altered communication between cells
Chronic inflammation
Dysbiosis
These processes do not occur independently.
Changes in one system can influence many others. Mitochondrial dysfunction can contribute to inflammation. Nutrient sensing influences autophagy. Senescent cells can change the behavior of surrounding tissues. The gut microbiome communicates with the immune, metabolic, and nervous systems.
This interconnectedness is one reason aging biology is so interesting therapeutically.
Instead of waiting until one organ develops disease, longevity research asks whether influencing these underlying pathways might support healthier function across multiple systems.
DNA Damage and Genomic Instability
Our DNA is constantly exposed to damage from normal metabolism, environmental exposures, radiation, inflammation, and other stressors.
Cells have extensive repair systems, but damage can accumulate over time.
When DNA repair becomes less efficient or damage exceeds a cell's ability to correct it, cellular function may become impaired.
Supporting genomic stability is therefore one of the fundamental challenges of healthy aging.
Telomere Attrition
Telomeres are protective structures at the ends of chromosomes.
They help prevent chromosome damage when cells divide.
Telomeres generally shorten with repeated cell division, although the rate varies considerably by person and tissue.
Very short or dysfunctional telomeres can cause cells to stop dividing or behave abnormally.
Telomere biology is important, but telomere length alone should not be viewed as a comprehensive measure of biological age.
Epigenetic Changes
Cells can change the way genes are expressed without changing the underlying DNA sequence.
These regulatory mechanisms are part of the epigenome.
Epigenetic patterns change with age, and these changes have led to the development of biological aging or epigenetic clocks.
These tools are becoming increasingly valuable in research because they may allow scientists to detect whether an intervention is influencing aspects of biological aging long before a lifespan study could be completed.
Like any biomarker, however, an epigenetic age should be interpreted as one piece of a larger picture rather than a precise countdown of remaining lifespan.
Proteostasis: Maintaining Healthy Proteins
Proteins perform much of the work inside our cells.
They need to be produced, folded correctly, repaired, and eventually removed when damaged.
The body's ability to maintain this balance is called proteostasis.
Loss of proteostasis becomes increasingly important with age and is especially relevant in conditions characterized by abnormal protein accumulation, including several neurodegenerative diseases.
Autophagy: Cellular Housekeeping
One way cells maintain themselves is through autophagy, a recycling process that helps remove damaged proteins and cellular components.
Impaired macroautophagy is now recognized as a distinct hallmark of aging.
Autophagy responds to nutrient availability, exercise, energy stress, and several important cellular signaling pathways.
This has generated considerable interest in interventions that may influence autophagy, including:
Exercise
Fasting and calorie restriction
Spermidine
Urolithin A
mTOR modulation
Other emerging nutritional and pharmaceutical strategies
Human measurement of autophagy remains difficult, but the field is progressing rapidly.
Rather than thinking of autophagy as an on/off switch that begins after a precise number of fasting hours, it is more useful to think of it as a dynamic cellular maintenance process that can be influenced by multiple factors.
Nutrient Sensing: mTOR and AMPK
Cells continually assess energy and nutrient availability.
Two central pathways in this process are mTOR and AMPK.
mTOR
mTOR responds to amino acids, insulin, growth factors, and energy availability.
When activated appropriately, mTOR supports:
Protein synthesis
Muscle growth
Tissue repair
Cell growth
Recovery
These are beneficial and necessary processes.
Chronic or excessive mTOR signaling, however, has been implicated in aging biology, which is why researchers are interested in strategies that periodically reduce mTOR activity.
AMPK
AMPK becomes more active when cellular energy availability is lower.
It helps shift metabolism toward energy production and cellular maintenance.
Exercise, fasting, and some nutritional compounds can influence AMPK signaling.
Healthy aging therefore does not mean maximizing AMPK and minimizing mTOR.
We need periods of building and repair as well as periods favoring maintenance and recycling.
The balance between these states may be more important than either pathway alone.
Sirolimus: Targeting mTOR
Sirolimus, also known as rapamycin, is one of the most studied pharmaceutical interventions in longevity biology.
Its ability to inhibit mTOR has extended lifespan and healthspan in numerous experimental models.
Human data are increasingly available as well.
A systematic review of rapamycin and related drugs found measurable effects in several physiological systems associated with aging, including immune, cardiovascular, and skin outcomes. Importantly, no serious adverse events attributable to rapamycin were reported among healthy participants in the included studies, although lipid changes, infection risk, glucose metabolism, and other potential effects remain relevant to monitoring.
Sirolimus is currently used off-label by some longevity physicians, frequently using dosing schedules that differ considerably from those used in transplant medicine.
Clinical questions remain regarding optimal dose, interval, duration, patient selection, and long-term outcomes. A 2025 review of low-dose rapamycin in healthy adults concluded that human evidence continues to develop and larger studies are warranted.
That uncertainty is one reason physician supervision and monitoring are important. It does not negate the substantial biological rationale and emerging human data that have made mTOR modulation one of the most active areas of longevity medicine.
Mitochondrial Dysfunction
Mitochondria are often described as the powerhouses of our cells, but their function extends well beyond energy production.
They participate in:
Metabolic regulation
Cellular signaling
Oxidative stress responses
Inflammation
Cell survival
Adaptation to exercise
Mitochondrial quality and efficiency can decline with age.
Exercise remains one of the most effective interventions for stimulating mitochondrial adaptation.
However, researchers are also studying compounds that may improve mitochondrial quality control.
Urolithin A and Mitophagy
Urolithin A is a metabolite that can be produced by certain gut bacteria from compounds found in foods such as pomegranates and walnuts.
Not everyone produces meaningful amounts of it naturally.
Urolithin A has attracted attention because of its ability to influence mitophagy, the process used to remove damaged mitochondria.
Human trials have now moved this intervention beyond purely theoretical or animal-model research.
A systematic review of five human studies reported dose-dependent anti-inflammatory effects and changes in mitochondrial gene expression, autophagy-related markers, and fatty-acid oxidation. Improvements in some measures of muscle strength and endurance were also observed.
These findings make urolithin A particularly interesting in the context of muscle health, mitochondrial aging, and physical resilience.
Research continues to determine which individuals are most likely to benefit and how these physiological changes translate into longer-term health outcomes.
NAD+: Cellular Energy and Repair
NAD+ is essential for numerous cellular processes, including:
Energy metabolism
Mitochondrial function
DNA repair
Cellular signaling
Activity of NAD-dependent enzymes such as sirtuins
NAD+ metabolism changes with age, helping drive interest in compounds that can support the body's NAD+ pool.
One of the most widely studied is nicotinamide mononucleotide, or NMN.
NMN
Randomized human studies consistently demonstrate that oral NMN can increase blood NAD-related metabolites. Results for downstream clinical measures vary among studies.
This variability is itself scientifically interesting.
Age, baseline NAD status, metabolic health, genetics, microbiome composition, dose, and other physiological differences may influence response. A review of NMN research has specifically highlighted this metabolic variability and the possibility that benefits may be context-dependent rather than uniform across populations.
Some recent analyses have identified modest physiological effects, including small reductions in blood pressure in certain groups of older adults.
For longevity medicine, this raises an important point:
An intervention does not necessarily need to produce the same effect in every study participant to have value in appropriately selected individuals.
Future research may increasingly help identify which patients are most likely to respond to NAD+ support and which biomarkers best reflect that response.
Cellular Senescence
Damaged or stressed cells sometimes permanently stop dividing. These are called senescent cells.
Cellular senescence is not inherently harmful. It is involved in wound healing, development, and protection against uncontrolled cellular growth.
Problems may develop when senescent cells accumulate.
Some produce inflammatory and signaling molecules collectively known as the senescence-associated secretory phenotype, or SASP, which can influence surrounding tissues.
This has led to development of two broad therapeutic strategies:
Senolytics, designed to selectively eliminate certain senescent cells
Senomorphics, designed to modify their inflammatory or damaging signals
Several nutritional and pharmaceutical compounds are being studied in this area.
Senotherapeutics remain one of the more experimental areas of longevity medicine, but they represent an important example of how understanding the biology of aging can create entirely new therapeutic targets.
Spermidine
Spermidine is a naturally occurring polyamine found in foods and produced within the body.
It has received attention for its effects on autophagy, mitochondrial function, cellular maintenance, and cognition.
Recent reviews describe emerging observational and interventional evidence suggesting potential effects on memory and cognitive aging, although clinical findings remain less mature than the extensive mechanistic literature.
Spermidine is another example of a compound for which mechanistic biology, nutritional exposure, and human intervention research are gradually converging.
Chronic Inflammation
Inflammation is essential for immune defense and tissue repair.
The problem is persistent, low-grade inflammatory signaling.
With age, chronic inflammation can arise from multiple sources, including:
Visceral fat
Metabolic dysfunction
Senescent cells
Immune-system changes
Poor sleep
Physical inactivity
Chronic disease
Changes in the gut microbiome
Inflammation therefore connects many of the hallmarks rather than functioning as an isolated pathway.
Dysbiosis and the Aging Microbiome
The trillions of microorganisms living within the gastrointestinal tract communicate with metabolic, immune, intestinal, and nervous systems.
Microbiome composition and function can change with age, diet, medication use, environment, illness, and lifestyle.
Because dysbiosis can influence inflammation, immunity, metabolic regulation, and intestinal-barrier function, it was added to the expanded Hallmarks of Aging framework.
This does not mean there is a single ideal “young microbiome” that can be recreated by taking one probiotic.
Instead, microbiome health is emerging as another highly individualized component of aging biology.
How Do We Decide Which Longevity Therapies Matter?
Longevity research moves faster than traditional decades-long clinical outcome trials can realistically answer every question.
That creates a need for thoughtful interpretation.
Rather than simply dividing therapies into “proven” and “unproven,” we can ask:
Is the biological target meaningful?
Does the intervention affect a pathway strongly implicated in aging biology?
Is there evidence in humans?
Human evidence might include changes in mitochondrial function, inflammatory markers, muscle performance, vascular function, immune responses, biological-age markers, or other relevant outcomes.
Is there a measurable individual response?
Objective testing can sometimes help determine whether an intervention is producing the desired physiological effect in a particular patient.
Is the intervention reasonably safe?
Dose, interactions, health history, monitoring, and long-term uncertainty all matter.
Does the potential benefit justify the risk and cost?
An intervention appropriate for one patient may not make sense for another.
This individualized approach allows longevity medicine to incorporate promising therapies while still respecting the limits of current knowledge.
Emerging Science and Clinical Practice
The science of healthy aging is evolving from observation toward intervention.
Exercise, nutrition, sleep, metabolic health, cardiovascular risk reduction, and muscle preservation provide the foundation.
Targeted therapies such as sirolimus, NAD+ precursors, urolithin A, spermidine, and other compounds add another layer by attempting to influence specific biological pathways associated with aging.
Some of these therapies will ultimately prove more valuable than others.
We should expect recommendations to evolve as studies become larger, longer, and more precise.
The goal is not to wait until every question has been answered before engaging with longevity science. Nor is it to assume that every promising laboratory finding will translate into meaningful human benefit.
The opportunity lies between those extremes: combining good science, appropriate caution, careful monitoring, and individualized clinical judgment.
Related Reading
Healthy Aging & Longevity
Return to our overview of the nutrition, lifestyle, medical, and functional factors that influence healthspan.
Fasting, Intermittent Fasting & the Fasting-Mimicking Diet
Learn how periods of reduced energy intake interact with nutrient sensing, metabolism, autophagy, and healthy aging.